CoaguChek® Vantus

CoaguChek Vantus
The future of INR self-testing

Trust in your patients’ self-testing results like never before. Accurate INR results are transmitted wirelessly via Bluetooth®-enabled CoaguChek® Vantus and can help improve patient compliance versus clinic-based testing, which may increase time in therapeutic range (TTR), and enable therapy decisions based on current results.1,2,3

CoaguChek Vantus
Benefits at a glance

Benefits at a glance

  • Easy to use. The CoaguChek® Vantus is designed with features to make accurate self-testing as easy and as repeatable as possible, including full-color display with easy-to-use on-screen instructions.
  • Minimal pain. The CoaguChek® XS Softclix Lancing Device is a specially designed lancing device that pricks the skin with a lancet to obtain just one drop of blood for testing.
  • Simplified patient experience. IDTF partners facilitate data result transfer and testing reminders, and make it easy to test from the comfort of your own home.
  • Seamless transfer of INR test results. With the CoaguChek® Vantus, no phone calls are needed and no manual entry on a web page is required. The results can be accurately reported via Bluetooth connectivity.
  • Product support. If you or your patients have product related questions, live technical support is available by phone at 1-800-428-4674.

Related categories

Training and support

Training and support

CoaguChek Vantus Training Video

CoaguChek Vantus Quick Reference Guide 

CoaguChek Vantus System User's Manual

CoaguChek XS PT Test Package Insert

Use left and right arrow keys to scroll between the tabs

Overview

Ordering Information

Technical Documents

multilangimg
   
Document repository
error errorMessage
Sorry, we couldn't find the content you are looking for
Please try again later

Related products

...
    ...

    Contact us

    Do you have questions about this product or service? We’re here to help. Fill out the form to contact a Roche representative.

    References

    1. Bluetooth connectivity requires a smartphone or tablet. Minimum specifications required.
    2. Kortke, H., Minami, K., Reymann, T., et al., (2001). “INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial).” Z Kardiol 90(6)118-124.
    3. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Meats E and Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet. 2006;367:404-411

    Call 1-800-428-4674 for a list of supported devices and operating systems.